Skip to main content

Find Clinical Trials

Home
Conditions
Hyperlipidemias

Clinical trial condition

Hyperlipidemias

Explore clinical trials studying Hyperlipidemias. Study availability and eligibility vary by location and protocol.

1,231 public trials 93 recruiting studies

Refine in advanced search Browse all conditions

Hyperlipidemias trial results

Completed

A Study to Assess the Cholesterol Lowering Effect of Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Elderly Patients With High Cholesterol at High or Moderately High Risk for Coronary Heart Disease (0653A-128)

NCT00535405

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)

NCT00462748

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)

NCT00276484

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)

NCT00418834

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139)

NCT00783263

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)

NCT00276458

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)

NCT01333436

Conditions: Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
Locations: MSD Korea Ltd. Seoul, South Korea

View Trial Details

Completed

An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

NCT03867110

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia

NCT04784442

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Tokyo-Eki Center-Building Clinic Chuo-ku,Tokyo, Japan

View Trial Details

Completed

Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)

NCT03884452

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +9 more
Locations: Not specified

View Trial Details